211 related articles for article (PubMed ID: 32264969)
1. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee.
Giancane G; Swart JF; Castagnola E; Groll AH; Horneff G; Huppertz HI; Lovell DJ; Wolfs T; Herlin T; Dolezalova P; Sanner H; Susic G; Sztajnbok F; Maritsi D; Constantin T; Vargova V; Sawhney S; Rygg M; K Oliveira S; Cattalini M; Bovis F; Bagnasco F; Pistorio A; Martini A; Wulffraat N; Ruperto N;
Arthritis Res Ther; 2020 Apr; 22(1):71. PubMed ID: 32264969
[TBL] [Abstract][Full Text] [Related]
2. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.
Swart J; Giancane G; Horneff G; Magnusson B; Hofer M; Alexeeva Е; Panaviene V; Bader-Meunier B; Anton J; Nielsen S; De Benedetti F; Kamphuis S; Staņēviča V; Tracahana M; Ailioaie LM; Tsitsami E; Klein A; Minden K; Foeldvari I; Haas JP; Klotsche J; Horne AC; Consolaro A; Bovis F; Bagnasco F; Pistorio A; Martini A; Wulffraat N; Ruperto N;
Arthritis Res Ther; 2018 Dec; 20(1):285. PubMed ID: 30587248
[TBL] [Abstract][Full Text] [Related]
3. High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.
Brunelli JB; Schmidt AR; Sallum AME; Goldenstein-Schainberg C; Bonfá E; Silva CA; Aikawa NE
Mod Rheumatol; 2018 Mar; 28(2):264-270. PubMed ID: 28949278
[TBL] [Abstract][Full Text] [Related]
4. Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.
Beukelman T; Xie F; Baddley JW; Chen L; Delzell E; Grijalva CG; Mannion ML; Patkar NM; Saag KG; Winthrop KL; Curtis JR;
Arthritis Rheum; 2013 May; 65(5):1384-9. PubMed ID: 23460423
[TBL] [Abstract][Full Text] [Related]
5. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
Nimmrich S; Horneff G
Rheumatol Int; 2015 Mar; 35(3):465-70. PubMed ID: 25583050
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry.
Thiele F; Klein A; Windschall D; Hospach A; Foeldvari I; Minden K; Weller-Heinemann F; Horneff G
Rheumatol Int; 2021 Apr; 41(4):751-762. PubMed ID: 33590331
[TBL] [Abstract][Full Text] [Related]
7. Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry.
Becker I; Horneff G
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):552-560. PubMed ID: 27390133
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
[TBL] [Abstract][Full Text] [Related]
9. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
[TBL] [Abstract][Full Text] [Related]
10. The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study.
Aygun D; Sahin S; Adrovic A; Barut K; Cokugras H; Camcıoglu Y; Kasapcopur O
Clin Rheumatol; 2019 Apr; 38(4):1025-1030. PubMed ID: 30448935
[TBL] [Abstract][Full Text] [Related]
11. A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
Batthish M; Berard R; Cabral D; Bolaria R; Chédeville G; Duffy C; Gerhold K; Gerschman T; Huber A; Proulx-Gauthier JP; Rosenberg A; Rumsey D; Schmeling H; Shiff N; Soon G; Bruns A; Tucker L; Guzman J;
Rheumatology (Oxford); 2020 Oct; 59(10):2796-2805. PubMed ID: 32044978
[TBL] [Abstract][Full Text] [Related]
12. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.
Foeldvari I; Constantin T; Vojinović J; Horneff G; Chasnyk V; Dehoorne J; Panaviene V; Sušić G; Stanevicha V; Kobusinska K; Zuber Z; Dobrzyniecka B; Nikishina I; Bader-Meunier B; Breda L; Doležalová P; Job-Deslandre C; Rumba-Rozenfelde I; Wulffraat N; Pedersen RD; Bukowski JF; Vlahos B; Martini A; Ruperto N;
Arthritis Res Ther; 2019 May; 21(1):125. PubMed ID: 31122296
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
14. Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
Kearsley-Fleet L; Sampath S; McCann LJ; Baildam E; Beresford MW; Davies R; De Cock D; Foster HE; Southwood TR; Thomson W; Hyrich KL
Rheumatology (Oxford); 2019 Feb; 58(2):331-335. PubMed ID: 30358861
[TBL] [Abstract][Full Text] [Related]
15. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
[TBL] [Abstract][Full Text] [Related]
16. Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes.
Jones JT; Smith C; Becker ML; Lovell D;
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1739-1745. PubMed ID: 33242376
[TBL] [Abstract][Full Text] [Related]
17. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.
Yamazaki S; Shimbo A; Akutsu Y; Takase H; Morio T; Mori M
Pediatr Rheumatol Online J; 2020 Mar; 18(1):26. PubMed ID: 32293465
[TBL] [Abstract][Full Text] [Related]
18. Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry.
Giancane G; Papa R; Vastert S; Bagnasco F; Swart JF; Quartier P; Antón J; Kamphuis S; Sanner H; Glerup M; De Benedetti F; Tsitsami E; Remesal A; Moreno E; De Inocencio J; Myrup C; Pallotti C; Koné-Paut I; Franck-Larsson K; Malmström H; Cederholm S; Pistorio A; Wulffraat N; Ruperto N;
J Rheumatol; 2022 Apr; 49(4):398-407. PubMed ID: 35105709
[TBL] [Abstract][Full Text] [Related]
19. Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries.
Kearsley-Fleet L; Klotsche J; van Straalen JW; Costello W; D'Angelo G; Giancane G; Horneff G; Klein A; Láday M; Lunt M; de Roock S; Ruperto N; Schoemaker C; Vijatov-Djuric G; Vojinovic J; Vougiouka O; Wulffraat NM; ; Hyrich KL; Minden K; Swart JF
Rheumatology (Oxford); 2022 May; 61(6):2524-2534. PubMed ID: 34613385
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Kimura Y; Schanberg LE; Tomlinson GA; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Weiss PF; Natter MD; Feldman BM; Ringold S;
Arthritis Rheumatol; 2021 Oct; 73(10):1898-1909. PubMed ID: 34105312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
